Coronavirus patent latest to complicates treatment

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an edited excerpt.

The outbreak of a novel coronavirus in the Middle East is raising worldwide health concerns and triggering questions about the ability of organizations to patent the genetic sequences of diseases for profit.

The virus was identified three months after the Erasmus Medical Center in Rotterdam, Netherlands, acquired a sample of it. The center has taken out a patent on the virus’s genetic sequence.

While Saudi officials and the WHO have said the patent will impede the process of containing the virus and developing treatments, Erasmus has defended the move.

Read the full story here: Can you patent a disease?

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend